Cancer Survival in England, cancers diagnosed 2018 to 2022, followed up to 2023

Users of cancer survival estimates include government organisations, health policymakers, cancer charities, academics and researchers, cancer registries, the public and the media. Population-based cancer survival statistics are used to:  

• monitor the implementation of the National Cancer Plan for England, including the ambition that “We will become a global leader on cancer survival by 2035” which will mean that “that 3 in every 4 people diagnosed in 2035 will be cancer-free or living well with cancer after 5 years”  

• demonstrate the pattern of survival by stage at diagnosis, to help show where earlier diagnosis could lead to improvements in survival  

• provide reliable and accessible information about cancer outcomes to a wide range of groups, including patients and health professionals via health awareness campaigns, cancer information leaflets and web pages  

Overall, cancer survival has been improving steadily in England and cancer mortality continues to decrease. Despite this, cancer survival in England remains lower than similar countries in Europe and around the world according to recent studies. These international comparisons have been reported by International Cancer Benchmarking Partnership (ICBP), EUROCARE-5 and CONCORD-3.